Hannah Wardill

Hannah Wardill is a researcher specializing in pharmacology, oncology, and microbiology, focusing on the interplay between chemotherapy, gut microbiota, and mucosal inflammation. Her work contributes to sustainable development goals related to health and well-being. She collaborates internationally on studies involving stem cell transplantation and gastrointestinal health.

• Research Interests: Mucositis, chemotherapy side effects, microbiome dynamics, and dietary interventions in oncology.

Her recent publications explore gut microbiota changes during chemotherapy, riboflavin's role in butyrate production, and protective dietary strategies. These studies highlight her focus on improving treatment efficacy while mitigating adverse effects.

No scientific awards are explicitly listed, but her work has garnered significant attention, including media mentions and social engagement. She has supervised one student, though details are not provided. Collaborations span institutions globally, reflecting her active role in interdisciplinary research.